日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of Hematopoietic Stem Cell Transplantation Regimen on Tacrolimus Pharmacokinetics.

造血干细胞移植方案对他克莫司药代动力学的影响

Oku Haruno, Yoshida Saki, Hotta Takumi, Muroi Hirohito, Fukushima Keizo, Irie Kei, Hirano Tatsuya, Shimomura Yoshimitsu, Ishikawa Takayuki, Ikesue Hiroaki, Muroi Nobuyuki, Hashida Tohru, Sugioka Nobuyuki

Effect of Diabetes on Outcomes in Patients With Incurable/Unresectable and Advanced/Recurrent Colorectal Cancer Receiving mFOLFOX6

糖尿病对接受 mFOLFOX6 方案治疗的不可治愈/不可切除及晚期/复发性结直肠癌患者预后的影响

Ikemura, Mai; Hirabatake, Masaki; Aburaya, Megumi; Ikesue, Hiroaki; Yasui, Hisateru; Muroi, Nobuyuki; Hashida, Tohru

Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma

多发性骨髓瘤患者从静脉注射改为皮下注射后达雷妥尤单抗的安全性和血药浓度

Yamaoka, Kenta; Irie, Kei; Hiramoto, Nobuhiro; Hirabatake, Masaki; Ikesue, Hiroaki; Hashida, Tohru; Shimizu, Tadashi; Ishikawa, Takayuki; Muroi, Nobuyuki

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer

日本非小细胞肺癌患者中纳武利尤单抗的群体药代动力学

Tohi, Makiko; Irie, Kei; Mizuno, Tomoyuki; Okuyoshi, Hiroyuki; Hirabatake, Masaki; Ikesue, Hiroaki; Muroi, Nobuyuki; Eto, Masaaki; Fukushima, Shoji; Tomii, Keisuke; Hashida, Tohru

Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication

接受血液透析的胶质母细胞瘤患者替莫唑胺的药代动力学:简短通讯

Tanaka, Fumiaki; Irie, Kei; Fukui, Nobuyuki; Horii, Ryo; Imamura, Hirotoshi; Hirabatake, Masaki; Ikesue, Hiroaki; Muroi, Nobuyuki; Fukushima, Shoji; Sakai, Nobuyuki; Hashida, Tohru

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide

药剂师-泌尿科医生协作管理可改善接受恩扎卢胺治疗的去势抵抗性前列腺癌患者的临床疗效。

Hirabatake, Masaki; Ikesue, Hiroaki; Iwama, Yuna; Irie, Kei; Yoshino, Shintaro; Yamasaki, Toshinari; Hashida, Tohru; Kawakita, Mutsushi; Muroi, Nobuyuki

Everolimus pharmacokinetics and exposure-response relationship in Japanese patients with advanced breast cancer

依维莫司在日本晚期乳腺癌患者中的药代动力学和暴露-反应关系

Hirabatake, Masaki; Mizuno, Tomoyuki; Kato, Hironori; Hashida, Tohru

Author Correction: Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database

作者更正:利用日本药物不良事件报告数据库分析化疗引起的周围神经病变

Inoue, Misaki; Matsumoto, Kiyoka; Tanaka, Mizuki; Yoshida, Yu; Satake, Riko; Goto, Fumiya; Shimada, Kazuyo; Mukai, Ririka; Hasegawa, Shiori; Suzuki, Takaaki; Ikesue, Hiroaki; Liao, Jun; Hashida, Tohru; Nakamura, Mitsuhiro

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis

地诺单抗和唑来膦酸治疗骨转移患者药物相关性颌骨坏死的风险评估:倾向评分匹配分析

Ikesue, Hiroaki; Doi, Kohei; Morimoto, Mayu; Hirabatake, Masaki; Muroi, Nobuyuki; Yamamoto, Shinsuke; Takenobu, Toshihiko; Hashida, Tohru

Association between 25-hydroxyvitamin D levels and COVID-19 severity

25-羟基维生素D水平与COVID-19严重程度之间的关联

Takase, Tomoki; Tsugawa, Naoko; Sugiyama, Takayuki; Ikesue, Hiroaki; Eto, Masaaki; Hashida, Tohru; Tomii, Keisuke; Muroi, Nobuyuki